Cargando...
4CPS-032 Study of the characteristics of patients treated with tolvaptan
BACKGROUND: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is one of the most frequent causes of hyponatraemia. Conventional treatments do not act on the vasopressin V2 receptor, are limited and with variable efficiency. Tolvaptan is the first selective vasopressin V2 receptor anta...
Gardado en:
Publicado en: | Eur J Hosp Pharm |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado: |
BMJ Group
2018
|
Assuntos: | |
Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535422/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.123 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|